Skip to main content
Table of Contents
Print

Can Cannabis CBD Alone Improve Breathing in Sleep Apnoea Patients? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Obstructive sleep apnoea (OSA)  affects millions, causing disrupted breathing and poor sleep quality. Recent research is exploring CBD for sleep apnoea to determine if cannabidiol alone can improve respiratory function during sleep. Evidence is emerging on cannabidiol for breathing and its potential role in CBD therapy for OSA. 

Potential Benefits of CBD in Sleep Apnoea 

Studies suggest CBD for sleep apnoea may offer supportive effects on airway stability and sleep regulation. 

Respiratory Modulation 

CBD for sleep apnoea may influence neural pathways controlling airway muscles, potentially aiding cannabidiol for breathing. 

Anti-Inflammatory Support 

CBD’s anti-inflammatory properties may reduce airway irritation, indirectly supporting CBD therapy for OSA. 

Sleep Quality Improvement 

Patients report more restful sleep and fewer disruptions when using CBD for sleep apnoea as part of their nightly routine. 

Daytime Functioning 

Improved breathing during sleep may enhance daytime alertness and energy, aligning with the goals of cannabidiol for breathing interventions. 

Adjunctive Strategy 

While CBD for sleep apnoea alone shows promise, it may be most effective when combined with standard OSA treatments. 

Current evidence suggests CBD for sleep apnoea could support respiratory function and sleep quality. Further studies are required to define optimal dosing and confirm the role of CBD therapy for OSA in clinical practice. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories